Product NDC: | 0270-0445 |
Proprietary Name: | Gastrografin |
Non Proprietary Name: | diatrizoate meglumine and diatrizoate sodium |
Active Ingredient(s): | 660; 100 mg/mL; mg/mL & nbsp; diatrizoate meglumine and diatrizoate sodium |
Administration Route(s): | ORAL; RECTAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0270-0445 |
Labeler Name: | BRACCO DIAGNOSTICS INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA011245 |
Marketing Category: | NDA |
Start Marketing Date: | 19580226 |
Package NDC: | 0270-0445-40 |
Package Description: | 12 BOTTLE in 1 BOX (0270-0445-40) > 120 mL in 1 BOTTLE |
NDC Code | 0270-0445-40 |
Proprietary Name | Gastrografin |
Package Description | 12 BOTTLE in 1 BOX (0270-0445-40) > 120 mL in 1 BOTTLE |
Product NDC | 0270-0445 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | diatrizoate meglumine and diatrizoate sodium |
Dosage Form Name | LIQUID |
Route Name | ORAL; RECTAL |
Start Marketing Date | 19580226 |
Marketing Category Name | NDA |
Labeler Name | BRACCO DIAGNOSTICS INC. |
Substance Name | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM |
Strength Number | 660; 100 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA],Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |